Evolution of bispecific and multispecific antibodies in cancer therapy.

Fontana E, Grochot R, Kotecki N, Doger B, Nannini S, de Miguel M

DOI: 10.1016/j.lanepe.2026.101599
Published: 2026 May
Container: The Lancet regional health. Europe
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.lanepe.2026.101599,
  title = {Evolution of bispecific and multispecific antibodies in cancer therapy.},
  author = {Fontana E and Grochot R and Kotecki N and Doger B and Nannini S and de Miguel M},
  year = {2026},
  journal = {The Lancet regional health. Europe},
  doi = {10.1016/j.lanepe.2026.101599},
  url = {https://doi.org/10.1016/j.lanepe.2026.101599}
}

RIS

TY  - JOUR
TI  - Evolution of bispecific and multispecific antibodies in cancer therapy.
AU  - Fontana E
AU  - Grochot R
AU  - Kotecki N
AU  - Doger B
AU  - Nannini S
AU  - de Miguel M
PY  - 2026
JO  - The Lancet regional health. Europe
DO  - 10.1016/j.lanepe.2026.101599
UR  - https://doi.org/10.1016/j.lanepe.2026.101599
ER  -

APA

E, F., R, G., N, K., B, D., S, N., & M, D. M. (2026). Evolution of bispecific and multispecific antibodies in cancer therapy.. The Lancet regional health. Europe. https://doi.org/10.1016/j.lanepe.2026.101599

Source records

pubmed · retrieved 2026-09-27T00:43:34.369Z